APA

Favier M., Le Goc-Sager F., Vincent-Cantini I., Launay V., Giroux E., Lièvremont K., Bonnet I., Barbe C., Duval E., Loric N. & Delbaldo C. (20181029). [Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)]. : Bulletin du cancer.

Chicago

Favier Mireille, Le Goc-Sager Fabienne, Vincent-Cantini Isabelle, Launay Vincent, Giroux Eric-Alban, Lièvremont Katia, Bonnet Isabelle, Barbe Catherine, Duval Eléa, Loric Nathanael and Delbaldo Catherine. 20181029. [Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)]. : Bulletin du cancer.

Harvard

Favier M., Le Goc-Sager F., Vincent-Cantini I., Launay V., Giroux E., Lièvremont K., Bonnet I., Barbe C., Duval E., Loric N. and Delbaldo C. (20181029). [Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)]. : Bulletin du cancer.

MLA

Favier Mireille, Le Goc-Sager Fabienne, Vincent-Cantini Isabelle, Launay Vincent, Giroux Eric-Alban, Lièvremont Katia, Bonnet Isabelle, Barbe Catherine, Duval Eléa, Loric Nathanael and Delbaldo Catherine. [Medico-economic benefits of subcutaneous formulations of trastuzumab and rituximab in day hospitalisation (SCuBA Study)]. : Bulletin du cancer. 20181029.